Repare Therapeutics Inc. reported a net loss of $84.7M in fiscal year 2024. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters Repare Therapeutics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RPTX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
RPTX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Repare Therapeutics Inc. financials
Frequently Asked Questions
What was Repare Therapeutics Inc.'s net income in fiscal year 2024?
Repare Therapeutics Inc. reported a net loss of $84.7M in fiscal year 2024.
How fast is Repare Therapeutics Inc.'s net income growing?
Repare Therapeutics Inc. (RPTX) reported a $93.8M net loss in fiscal year 2023 and a $84.7M net loss in fiscal year 2024. A growth rate is not meaningful here, because the earlier figure was zero or negative.
How has Repare Therapeutics Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, Repare Therapeutics Inc. (RPTX) net income went from -$27.2M in fiscal year 2019 to -$84.7M in fiscal year 2024.
What was Repare Therapeutics Inc.'s net income in the most recent quarter?
Repare Therapeutics Inc. (RPTX) reported $3.3M in net income in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Repare Therapeutics Inc. (RPTX) reported on that line in every period on record.